@DanielVargasMD @RadiologiaChile @INCIC_Chile @NASCISociety @circlecvi Incredible setup for the first-ever 🇨🇱hands-on CMR workshop using dedicated imaging software @circlecvi endorsed by @SCMRorg and @NASCISociety ! And sponsored by @GEHealthCare | Steering #WhyCMR forward is an all-hands-on-deck job!

Aficamten vs metoprolol responder analysis. How many more trials in oHCM and myosin inhibition are needed prior to establishing LVOT gradients/LVEF, (supported by NTproBNP and safety) as the outcome? Placebo effect on NYHA/KCCQ is sizable, while pVO2 continues to provide a

1: “Longitudinal strain” is not the real longitudinal shortening, as it adds the effect of inward tracking. 2: The inward gradient of longitudinal strain is an artefact of feature tracking.

#EHJCVI 🫀ICD selection in NICM isn’t just about LVEF <35% or LGE %, location matters 📌 Midwall LGE identifies patients with higher MAACE risk ⚡DERIVATE Risk Score 2.0 (LGE location + LVEF + sex) delivers a +54% NRI vs LVEF alone. Read more 👉 https://t.co/rF396dN85g

Join us next week CVCT - Cardiovascular Clinical Trialists for exciting sessions covering amyloid, HCM, genetic cardiomyopathies and gene therapies https://t.co/46Tc2df3Je #cardiotwitter

⚡️ Recovered sudden cardiac arrest + ICD, no prior CMR 🧲 Very small body habitus → ICD extremely close to the heart➡️device artifact almost impossible to manipulate Yet, diagnostic-quality #WhyCMR achieved✅

Mental picture every time someone says they want a “formal echo” @NanoBanana

HOME MADE GREY BLOOD LGE: A MUST in #WhyCMR 🧲

It is fascinating that an anatomic study has confirmed what echocardiography previously suggested: tricuspid valve is not tricuspid most of the times due to leaflet scalloping, most commonly of the posterior leaflet. https://t.co/Ed4QZqWcFC

😎 Another one! #WhyCMR

Cardiac MRI high-risk features among individuals with tricuspid regurgitation include a TR fraction ≥40% and liver extracellular volume @sarano_maurice @PhilippLurz @hahn_rt @j_hausleiter @Miho_Fukui_ @JoaoLCavalcante https://t.co/jcM7r7MlGT

A post hoc analysis from ATTRibute-CM where acoramidis improved clinical outcomes regardless of AF status #cardiotwitter #AHA2025 #MedIQAHA25

#AHA25 starts tomorrow! Don't miss @MasriAhmadMD posting live updates on ATTR-CM from the meeting. #MedIQAHA25

#Whycmr data on vutrisiran in #ATTR #CM #AHA2025 #MedIQAHA25

#AHA2025 In cardiac #amyloidosis, this EKG algorithm had 97% sens and 40% spec for the diagnosis. This impacts accuracy. #cardiotwitter #MedIQAHA25

⚡️ Recovered sudden cardiac arrest + ICD, no prior CMR 🧲 Very small body habitus → ICD extremely close to the heart➡️device artifact almost impossible to manipulate Yet, diagnostic-quality #WhyCMR achieved✅

🧲+💯+🆓+🫁 =Comprehensive CMR in a 7-year-old, 100% free breathing, no anesthesia or sedation. - Motion correction made a full diagnostic study possible without a single breath hold! - Fine-tuning & technology break access barriers in #whyCMR https://t.co/2aeypSqnS1

⏱️ Late-presenting STEMI ➡️fibrinolysis due to post-infarction angina and lack of PCI access 📉 CMR extensive proximal LAD infarction with extensive MVO+IMH ⚠️ Consequences of delayed reperfusion and #WhyCMR power🧲 to define injury and prognosis @SCMRorg @INCIC_Chile

No 🧲 #4DFLOW no problema! We got you covered! 🍭+🦯=🤣

⏱️ Late-presenting STEMI ➡️fibrinolysis due to post-infarction angina and lack of PCI access 📉 CMR extensive proximal LAD infarction with extensive MVO+IMH ⚠️ Consequences of delayed reperfusion and #WhyCMR power🧲 to define injury and prognosis @SCMRorg @INCIC_Chile

🧲+💯+🆓+🫁 =Comprehensive CMR in a 7-year-old, 100% free breathing, no anesthesia or sedation. - Motion correction made a full diagnostic study possible without a single breath hold! - Fine-tuning & technology break access barriers in #whyCMR https://t.co/2aeypSqnS1